Surgical Oncology
Volume 21, Issue 1 , Pages 1-5, March 2012

Peritoneal pseudomyxoma arising from the urachus

  • Alejandra Martínez

      Affiliations

    • Institut Claudius Regaud (ICR), Surgery, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 650493489; fax: +33 561424117.
    • ,
  • Gwénael Ferron

      Affiliations

    • Institut Claudius Regaud (ICR), Surgery, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Eliane Mery

      Affiliations

    • Institut Claudius Regaud (ICR), Pathology, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Laurance Gladieff

      Affiliations

    • Institut Claudius Regaud (ICR), Medical Oncology, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Jean Pierre Delord

      Affiliations

    • Institut Claudius Regaud (ICR), Medical Oncology, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France
    • ,
  • Denis Querleu

      Affiliations

    • Institut Claudius Regaud (ICR), Surgery, 20-24, Rue du Pont Saint Pierre, 31052 Toulouse, France

Accepted 29 December 2009. published online 17 October 2011.

Abstract 

Pseudomyxoma peritonei (PMP) arising from urachal tumors is extremely rare. To our knowledge, natural history, tumor biological behaviour, morbidity, treatment, and prognosis of PMP arising from the urachus are determined by the associated PMP. Management of urachal tumors with associated PMP should be based on aggressive locorregional therapy with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, similar to PMP arising from other origins.

Keywords: Urachus, Pseudomyxoma, HIPEC, Peritonectomy, Cytoreductive surgery

 

PII: S0960-7404(10)00002-2

doi:10.1016/j.suronc.2009.12.004

Surgical Oncology
Volume 21, Issue 1 , Pages 1-5, March 2012

Article Tools

* Image Usage & Resolution